...
CIPM 2026 Q&A cover: pellet and 3-in-1 granulation at JIANPAI booth
CIPM 2026: preguntas y respuestas sobre granulación centrífuga frente a extrusión y el granulador 3 en 1
From October 27 to 29, 2026, the 68th China National Pharmaceutical Machinery Expo (CIPM 2026) filled...
CIPM 2026 Q&A cover: smart OSD, mixing and coating at JIANPAI booth 2-B27
CIPM 2026: preguntas y respuestas sobre fabricación OSD inteligente, mezcla triple excéntrica y recubrimiento
At CIPM 2026 in Xiamen (October 27-29, 2026), visitors to JIANPAI Booth 2-B27 did not ask for brochures....
JianPai Technology team at CIPM 2026 Xiamen
JianPai Technology concluye con éxito su participación en CIPM 2026 Xiamen
JianPai Technology wraps up CIPM 2026 Xiamen at Booth 2-B27 (Oct 27–29): fluid bed and high-shear granulators,...
Top generic pharma manufacturing companies in Indonesia 2026 B2B shortlist cover with JIANPAI fluid bed equipment
Principales fabricantes de genéricos en Indonesia: lista corta B2B 2026
Indonesia’s generics market is shaped by BPOM licensing, CPOB (GMP) expectations, and JKN / e-catalogue...

SOBRE NOSOTROS

Acerca de nosotros - Presentación de nuestro equipo,
Misión, y valores.

Ranking 2026 de las 50 mayores farmacéuticas del mundo

Ranking 2026 de las 50 mayores farmacéuticas del mundo

The global pharmaceutical industry continues to experience strong growth driven by innovation in biologics, oncology, diabetes and obesity treatment, vaccines, and rare disease therapies. In August 2026, Pharm Exec magazine published the 2026 Pharm Exec 50, ranking the Top 50 pharmaceutical companies worldwide by prescription drug (Rx) sales in fiscal year 2025.

This ranking is widely regarded as one of the most authoritative industry benchmarks, offering valuable insight for pharmaceutical manufacturers, API and packaging suppliers, pharmaceutical equipment companies, and distributors and contract manufacturing organizations (CMOs).

Below is the fully updated 2026 Global Top 50 Pharmaceutical Companies List, based on 2025 Rx sales.

Metodología de clasificación

  • Fuente de clasificación: Pharm Exec magazine (2026 Pharm Exec 50, published August 14, 2026)
  • Base de clasificación: Global prescription drug (Rx) sales
  • Año fiscal: 2025
  • Año de publicación de la clasificación: 2026

Esta clasificación refleja rendimiento comercial real, not market capitalization or valuation. Figures in the table are 2025 Rx sales, shown in US$ billion.

2026 Global Top 50 Pharmaceutical Companies (Complete List)

Rango Compañía Sede 2025 Rx sales (US$ billion)
1 Eli Lilly EE.UU 60.78
2 Johnson & Johnson EE.UU 59.33
3 Abbvie EE.UU 58.27
4 roche Suiza 57.51
5 AstraZeneca Reino Unido 55.04
6 Merck & Co. (MSD) EE.UU 54.69
7 Novartis Suiza 54.33
8 Pfizer EE.UU 49.91
9 sanofi Francia 48.97
10 Bristol-Myers Squibb EE.UU 47.75
11 Novo Nordisk Dinamarca 46.80
12 GSK (GlaxoSmithKline) Reino Unido 42.72
13 amgen EE.UU 34.95
14 Takeda Japón 29.67
15 Ciencias de Galaad EE.UU 28.83
16 Boehringer-Ingelheim Alemania 23.82
17 Bayer Alemania 19.19
18 CSL Australia 15.44
19 viatris EE.UU 14.09
20 tevá Israel 14.08
21 Astellas Japón 12.60
22 Daiichi Sankyo Japón 12.04
23 Farmacéutica Vértex EE.UU 11.97
24 Grupo Sandoz Suiza 11.09
25 Otsuka Holdings Japón 9.87
26 Merck KGaA Alemania 9.73
27 UCB Bélgica 8.24
28 Grifols España 7.33
29 biogeno EE.UU 7.12
30 Farmacia del Sol India 6.44
31 Regenerón EE.UU 6.31
32 organon EE.UU 6.06
33 Yunnan Baiyao Porcelana 5.72
34 Abbott EE.UU 5.51
35 servidor Francia 5.44
36 Bausch Health Canadá 5.41
37 BeOne Medicines (formerly BeiGene) Suiza 5.28
38 Fresenius Alemania 5.21
39 Shanghai Pharmaceuticals Porcelana 5.16
40 Eisai Japón 4.78
41 Sino Biopharmaceutical Hong Kong 4.37
42 Menarini Italia 4.36
43 incitar EE.UU 4.35
44 Ipsen Francia 4.16
45 argenx Países Bajos 4.15
46 Farmacéutica Jazz Irlanda 4.02
47 STADA Alemania 4.02
48 Medicina Huadong Porcelana 3.97
49 Medicina de Jiangsu Hengrui Porcelana 3.85
50 Haleon Reino Unido 3.60

Data source: Pharm Exec, 2026 Pharm Exec 50 (FY 2025 prescription drug sales). Company names use common English forms; BeOne Medicines appears under its current name (formerly BeiGene).

Key Industry Trends from the 2026 Ranking

1. Eli Lilly Rises to No. 1

The headline change this year is Eli Lilly’s jump from No. 11 in the previous ranking to No. 1, with about $60.8 billion in 2025 Rx sales, up roughly 49% year over year. Johnson & Johnson, last year’s leader, is now No. 2. AbbVie, Roche, and AstraZeneca complete the top five.

2. U.S. Companies Continue to Lead by Count

Fifteen companies in the Top 50 are headquartered in the United States, still the largest national group, with particular strength in oncology, immunology, biologics, and metabolic disease, including GLP-1 therapies.

3. Switzerland, Japan, and Germany Remain Innovation Hubs

Switzerland is represented by Roche, Novartis, Sandoz, and BeOne Medicines (formerly BeiGene, now listed with a Swiss headquarters). Japan remains well represented by Takeda, Astellas, Daiichi Sankyo, Otsuka, and Eisai. Germany includes Boehringer Ingelheim, Bayer, Merck KGaA, Fresenius, and STADA.

4. China Holds Five Places; India Is Represented by Sun Pharma

Five Chinese companies are in this year’s list if Sino Biopharmaceutical (Hong Kong) is included: Yunnan Baiyao, Shanghai Pharmaceuticals (a new entrant), Sino Biopharmaceutical, Huadong Medicine, and Jiangsu Hengrui Medicine. CSPC Pharmaceutical Group is no longer in the Top 50. From India, Sun Pharma remains on the list; Dr. Reddy’s Laboratories is not in this year’s Top 50. New global entrants also include argenx (Netherlands) and Haleon (UK).

Por qué esta clasificación es importante para los proveedores farmacéuticos

If you are involved in pharmaceutical machinery manufacturing, packaging solutions (vials, bottles, blister, ampoules), API and excipient supply, or contract manufacturing (CDMO/CMO), this list directly reflects where purchasing power is concentrated, which companies control global drug production, and who your most valuable long-term customers may be.

Outlook for the Global Pharmaceutical Industry in 2026

Based on this ranking, the pharmaceutical industry will continue focusing on biologics and biosimilars, GLP-1 diabetes and obesity drugs, cancer immunotherapy, rare disease treatments, and personalized medicine. Companies at the top of the 2026 Pharm Exec 50 are expected to drive mergers and acquisitions, equipment upgrades, and new plant investments worldwide.

¿Qué equipo utilizan estos líderes farmacéuticos?

La mayoría de las empresas de este ranking realizan grandes operaciones de dosis sólidas orales (OSD) junto con productos biológicos. Sus plantas de tabletas y cápsulas están construidas alrededor de una cadena de proceso similar, y cada paso necesita equipos de grado GMP que produzcan lotes repetibles. Cubrimos esto en detalle en ¿Qué equipos utilizan las 50 principales empresas farmacéuticas del mundo para garantizar la calidad?.

Paso del proceso Objetivo Equipos JIANPAI relacionados
Granulación húmeda Densifique los polvos y mejore el flujo y la uniformidad del contenido. Granuladores mezcladores de alto cizallamiento (JHZ-C, JHZ-D)
El secado Reducir la humedad de los gránulos al nivel validado. Secadores de lecho fluido (JFG-C)
Dimensionado y fresado Controle el tamaño de las partículas antes de mezclar Molinos farmacéuticos (Granulador de tamaño JZL)
Mezcla Mezclar gránulos con lubricantes y excipientes. Licuadoras farmacéuticas (Mezclador JPH de tres excentricidades)
Recubrimiento Película, azúcar o recubrimiento entérico de tabletas. Máquinas de recubrimiento de tabletas (JGB-D, JGB-E)
Líneas integradas Líneas de granulación cerradas y enlazadas que reducen la manipulación manual Línea de producción de granulación totalmente cerrada, fabricación continua

Los fabricantes genéricos y contratados que suministran a estos líderes, o compiten con ellos, a menudo comparan sus propias líneas con los mismos estándares. Para la planificación del presupuesto, consulte nuestro Guía de precios de la máquina de recubrimiento de tabletas..

Conclusión

El 2026 Global Top 50 Pharmaceutical Companies Ranking provides a clear overview of the world’s leading drug manufacturers, based on 2025 prescription drug sales, and reflects the direction of the global pharmaceutical industry. From biologics and oncology to diabetes, obesity, and rare disease therapies, these top companies will continue to drive innovation, capacity expansion, and equipment upgrades worldwide.

Como fabricante profesional de maquinaria farmacéutica, Jianpai closely follows the development trends of these global pharma leaders and is committed to providing reliable, high-efficiency production and processing solutions for pharmaceutical manufacturers across the world. Whether you are planning a new production line, upgrading existing equipment, or expanding your formulation and packaging capacity, JIANPAI offers customized solutions to meet your exact needs.

Preguntas frecuentes

Who is the largest pharmaceutical company in the 2026 ranking?

Eli Lilly is No. 1 in the 2026 Pharm Exec 50, with about $60.8 billion in 2025 prescription (Rx) drug sales. Johnson & Johnson is No. 2. The complete Top 50 table above ranks companies by 2025 Rx sales, as described in the methodology section.

What equipment do top pharmaceutical companies use for oral solid dosage?

Large OSD plants typically run high shear wet granulation, fluid bed drying, milling and sizing, blending, tablet compression, and film or functional coating, often with closed material transfer and automated cleaning.

Why does this ranking matter for equipment suppliers?

Top companies set the quality and compliance expectations that generic and contract manufacturers follow. Equipment that meets their GMP, data integrity and containment needs is increasingly expected across the industry.

¿Está planificando una línea OSD según los estándares globales?

JIANPAI suministra equipos de granulación, secado, molienda, mezcla y recubrimiento para plantas de dosificación de sólidos orales. Envíenos sus productos y capacidad objetivo para una propuesta de línea.

Correo electrónico: [email protected] | Teléfono: +86 577-86932456 | No. 989 Lingde Road, nuevo distrito de Oujiangkou, Wenzhou, Zhejiang, China

es_ESES

Cuéntanos tu Requisitos Preguntas Necesidades Ideas Planes